A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease
Non-invasive urinary peptide biomarkers are able to detect and predict chronic kidney disease (CKD). Moreover, specific urinary peptides enable discrimination of different CKD etiologies and offer an interesting alternative to invasive kidney biopsy, which cannot always be performed. The aim of this...
Main Authors: | Lorenzo Catanese, Justyna Siwy, Emmanouil Mavrogeorgis, Kerstin Amann, Harald Mischak, Joachim Beige, Harald Rupprecht |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Proteomes |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-7382/9/3/32 |
Similar Items
-
Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review
by: Lorenzo Catanese, et al.
Published: (2023-05-01) -
Urinary MicroRNA-21-5p as Potential Biomarker of Interstitial Fibrosis and Tubular Atrophy (IFTA) in Kidney Transplant Recipients
by: Michal S. Gniewkiewicz, et al.
Published: (2020-02-01) -
Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
by: Emmanouil Mavrogeorgis, et al.
Published: (2021-11-01) -
Molecular Mapping of Urinary Complement Peptides in Kidney Diseases
by: Ralph Wendt, et al.
Published: (2021-12-01) -
Collagen-Derived Peptides in CKD: A Link to Fibrosis
by: Emmanouil Mavrogeorgis, et al.
Published: (2021-12-01)